Back to Search
Start Over
Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians
- Source :
- Journal of Eating Disorders, Vol 12, Iss 1, Pp 1-9 (2024)
- Publication Year :
- 2024
- Publisher :
- BMC, 2024.
-
Abstract
- Abstract Background Clinical trials using psilocybin therapy to treat anorexia nervosa (AN) are currently underway. The safety and tolerability of psilocybin is of utmost importance in individuals with AN who may present unique medical vulnerabilities. The purpose of this review is to describe how the common physiologic adverse effects of psilocybin may impact medical complications experienced by individuals with AN in clinical trials of psilocybin therapy. Main body The physiologic underpinnings of common adverse effects following psilocybin administration are described, including tachycardia, hypertension, electrocardiogram changes, nausea, headache, and lightheadedness. These anticipated physiologic changes are described in relation to the common medical correlates seen in individuals with AN. Risk mitigation strategies for each adverse effect are proposed. Conclusion Early evidence suggests that psilocybin therapy is well-tolerated in individuals with AN. Understanding the unique medical complications of AN, and how they may be impacted by common physiologic adverse effects of psilocybin administration, leads to tailored risk mitigation strategies to enhance safety and tolerability of this novel intervention.
- Subjects :
- Psilocybin
Anorexia nervosa
Clinical trial
Adverse effects
Psychiatry
RC435-571
Subjects
Details
- Language :
- English
- ISSN :
- 20502974
- Volume :
- 12
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of Eating Disorders
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.553c0db8bb6648e7b3c7e79dde7d8bbf
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s40337-024-01005-z